throbber
AQUESTIVE EXHIBIT 1076 Page 0001
`
`AQUESTIVE EXHIBIT 1076 Page 0001
`
`

`

`CeRRLeI
`
`THE
`
`MERCK INDEX
`
`AN ENCYCLOPEDIA OF
`
`CHEMICALS, DRUGS, AND BIOLOGICALS
`
`TWELFTH EDITION
`
`Susan Budavari, Editor
`Maryadele J. O'Neil, Senior Associate Editor
`Ann Smith, Associate Editor
`Patricia E. Heckelman, Assistant Editor
`Joanne F. Kinneary, Assistant Editor
`
`Published by
`Merck Research Laboratories
`Division of
`
`MERCK & CO., Inc.
`
`Whitehouse Station, NJ
`
`1996
`
`AQUESTIVE EXHIBIT 1076 Page 0002
`
`AQUESTIVE EXHIBIT 1076 Page 0002
`
`

`

`
`
`MERCK & CO., INC.
`WhitehouseStation, N.J.
`US.A.
`
`1st Edition—1889
`2nd Edition—1896
`3rd Edition—1907
`4th Edition—1930
`5th Edition—1940
`6th Edition—1952
`7th Edition—1960
`8th Edition—1968
`Oth Edition—1976
`10th Edition—1983
`11th Edition—1989
`
`Library of Congress Catalog
`Card Number 89-60001
`ISBN Number 091 1910-12-3
`
`First Printing—March 1996
`Second Printing—April 1997
`
`Witht
`
`century «
`ciplinary
`lished in
`cation ov
`the text
`biochem
`tion of iu
`of discip
`mind, bu
`lence in.
`This e
`which m
`ticals, ov
`and anot
`tional 1,(
`almost 1
`hundred«
`A num
`lished in
`chemical
`chemical
`scriptors
`readershij
`1983 in th
`of Chemi
`panded. §
`some of1
`and immt
`In reco
`reference
`major onl
`whichis t
`Compa:
`unparallel
`ronment,
`refer to Tl
`by Merck
`the traditi:
`
`Copyright © 1996 by MERCK & CO., INC.
`All rights reserved. Copyright under the Universal Copyright Convention
`and the International Copyright Convention.
`Copyrightreserved under the Pan-American Copyright Convention.
`Printed in the U.S.A.
`
`AQUESTIVE EXHIBIT 1076 Page 0003
`AQUESTIVE EXHIBIT 1076 Page 0003
`
`
`
`

`

`0
`
`rackets indicates optical rotation
`
`Bu
`
`butyl
`
`ca.
`
`al similari-
`
`iged alpha-
`mberorder.
`=
`os
`derivatives.
`unspecified
`
`BOC
`oe
`oil.
`bp
`
`Abbreviations and Selected Definitions
`Please consult the Glossary (Misc. Tables Section) for additional definitions.
`adenine; adenosine; absorbance
`A.S.T.M.
`American Society for Testing
`A
`2 (extinction)
`Materials
`.
`ngstrom units
`as-, asym-
`asymmetrical, unsymmetrical
`A
`o-antitrypsin
`atomic
`at.
`‘AAT
`antibody
`ATCC
`American Type Culture Collection
`Ab
`absolute; absorption
`atm, atmos
`atmosphere(s), atmospheric
`abs
`aot configuration
`at. no.
`atomic number
`abs config
`abstract .
`ATP
`adenosine triphosphate
`abstr
`;
`a-aminobutyric acid
`ATPase
`adenosine triphosphatase
`‘Abu
`e. Inclusion
`acetyl CH;CO—
`at. wt.
`atomic weight
`Ac
`sement, but
`according
`BAN
`British Approved Name
`acc
`angiotensin converting enzyme
`B cell
`bone marrow or bursa of Fabricius
`ACE
`RAPEUTIC
`acetyl coenzyme A
`derived cell
`Acetyl CoA
`)
`paragraphs
`acetic anhydride
`BCG
`Bacillus Calmette-Guerin
`Ac,O
`p
`:
`ethyl acetate
`Baumé(a specific gravity scale)
`Bé
`AcOEt
`al properties
`oe acid
`2
`Beilstein
`Raliiein’s Bendeh der
`AcOH
`srmation Gf
`acyl carrier protein
`rganischen Chemie
`A
`American Chemical Society
`Belg.pat.
`Helen patent
`ACS.
`ad to consult
`airenadoeiifotropte hormone
`Ber.
`Cee eee (Berichte der
`ute -
`saat
`acyl coenzyme
`eutschen Chemischen
`Acy!SCo.
`_info
`antibody-dependentcellular
`Gesellschaft)
`ADCC
`ie respective
`cytotoxicity
`BGG
`bovine gammaglobulin
`p'
`adding, addition
`biological
`biol
`add(n)
`adenine
`BLOS.
`British Intelligence Objectives
`Ade
`algehel dehydrogenase
`Subcommittee
`ADH
`antly updated
`adenosine diphosphate
`tert-butoxycarbonyl
`ADP
`:
`ates States) Atomic Energy
`biochemical ae demand
`AEC
`ae each
`ommission
`oilin:
`in index.
`antigen, silver
`hasepait boiling point; boils at;
`Ag
`1
`-
`anaphylotoxin inhibitor
`boiling atExample: bp7o 48°
`AI
`a glossary,
`AIDS eee
`ee bats at 48°C ifthe pressure
`‘.
`. is70mm
`
`ion contained
`Ala
`alanine |
`British_
`B.P.
`h
`alc, alcoh
`alcohol(ic); ethanol; ethyl alcohol
`British Pharmaceutical Codex
`nat be
`B.P.C.
`er can
`a
`aie globulin
`Brit. pat.
`British patent
`nces arisin
`alkali(ne)
`_
`;
`BRM
`biological response modifier
`
`
`
`
`ie specific opticalrotation at 25°C for|BSA: e [ale bogie enumalbanian
`
`cordingly, rei-
`pee absence of
`Btu
`British thermal units
`o ie and
`ofa liquid in a 1 decimetercell,
`Bz
`heey C.H;CO—
`de in
`the nex
`neat
`BzH
`benzaldehyde
`
`ALS anti-lymphocyteserum, amyotrophic|BzOH benzoic arid
`
`lateral sclerosis
`;
`c
`concentration by volume (g/100ml)
`amy,
`molar absorptivity (concn in
`after optical rotations only
`g-moles/l)
`GC
`cytosine; cytidine; complement
`amorph
`amorphous
`Centigrade degrees; Celsius
`°C
`adenosine5’-monophosphate
`degrees
`AMP
`cAMP
`\epeeacid)
`Cc,
`ee ee (constant pressure)
`cyclic
`circa) about
`aus)
`aaeenl ,
`oe
`ieneAbstracts
`calorie(s
`c
`amount(s
`ANF
`anti-nuclear factor; atrial natriuretic
`calc(d)
`calculate, calculated
`factor
`Can.pat
`Canadian patent
`anhydr
`anhydrous
`Cbz
`carbobenzoxy
`stereodescriptor, see Glossary
`cbe
`complete blood count
`anti
`ou,
`coe aed’s Annalen der Chemie
`cc
`cubic centimeter(s) (milliliter)
`merican
`Pharmaceutical
`CCK
`cholecystokinin
`Association
`cD
`Greatilae dichroism
`approx
`approximate(ly)
`;
`CDP
`cytidine diphosphate
`alum precipitated toxoid
`CEA
`carcinoembryonic antigen
`APT
`al
`aqueous
`of.
`(confer) compare
`.
`A
`.
`CFA
`complete Freund’s adjuvant (same as
`-R.
`analytical reagent
`FCA)
`ARC
`AIDSrelated complex
`CFT
`complementfixation test
`Archiv Exp.
`Naunyn Schmiedebergs Archivfiir
`coronary heart disease
`CHD
`rear
`Experimentelle Pathologie und
`CHF
`congestive heart failure
`harmakol.
`Pharmakologie
`chem
`chemical
`re is
`aromatic acyl radical
`Chem. Commun.
`Journal ofthe Chemical Society,
`arginine .
`;
`Chemical Communications.
`Ac
`nN a
`B-carboxyaspartic acid
`Ci
`curie
`ia
`asparagine
`CI.
`Colour Index (British)
`a Sp
`aspartic acid
`cis-
`stereodescriptor, see Glossary
`ssoc(d)
`association; associated
`cm
`centimeter(s)
`
`xiii
`
`AQUESTIVE EXHIBIT 1076 Page 0004
`
`AQUESTIVE EXHIBIT 1076 Page 0004
`
`

`

`
`
`monomeric units in the polymer) D.R.P.
`
`ds
`
`dyn
`(E)-
`1%
`Eicm
`
`O-(carboxymethyl) cellulose
`cell-mediated immunity
`cell-mediated lymphocytotoxicity
`cytidine 5'-monophosphate (cytidylic
`‘acid)
`central nervous system
`coenzyme A
`collective volume
`compound
`composition
`concanavalin A
`concentrated
`concentration
`configuration
`constituent
`continued
`containing
`coenzyme Q (ubiquinone)
`corrected |
`corresponding, corresponds
`centipoise
`chemically pure
`compound
`critical pressure
`critical temperature
`crystalline, crystals
`crystallization
`colony stimulating factor; cerebral
`spinal fluid
`Cosmetic, Toiletry and Fragrance
`Assoc.
`cytidine triphosphate
`cysteine
`cytosine
`density; specific gravity (di? specific
`gravity at 19° referred to water at
`dextro(rotatory), the opposite of 1
`dextro (in configurational sense
`only), the opposite of L
`daltons
`O-(diethylaminoethyl)cellulose
`decompose(s), decomposition
`decomposition
`degree
`deliquescent
`indicates the locant of the double
`bond
`derivative
`determination
`diisopropyl fluorophosphateor
`diisopropyl phosphofluoridate
`dihydroalanine
`dehydrobutyrine,
`§-methyldehydroalanine
`difference
`dilute, diluted, dilution
`distillation
`racemic
`optically inactive by external
`compensation as contrasted with
`meso-
`decimeter(s)
`dimethylacetamide
`disease modifying antirheumatic drug
`dimethylformamide
`dimethylsulfoxide
`deoxyribonucleic acid
`complementary DNA
`mitochondrial DNA
`deoxyribonuclease
`2,4-dinitro-1-fluorobenzene
`oAtipirepeny or 2,4-
`dinitrophenol
`dihydroxyphenylalanine
`degree of polymerization (number of
`
`CM-cellulose
`CMI
`CML
`CMP
`
`CNS
`CoA or CoASH
`coll. vol.
`compd
`compn
`Con A
`conc(d)
`concn
`config
`constit
`contd
`contg
`CoQ
`cor(r)
`corresp
`cp
`CP.
`cpd
`crit press
`crit temp
`cryst
`crystn
`CSF
`
`CTFA
`
`CTP
`
`yt
`
`d d
`
`-
`D-
`
`Da
`DEAEcellulose
`dec, decomp
`decompn
`deg
`deliquesc
`A (delta)
`
`deriv
`determn
`DFP, DIFP, DIPF
`
`Dha
`Dhb
`
`diff
`dil(d), (n)
`distin
`dl-
`DL-
`
`dm
`DMA
`DMARD
`DMF
`DMSO
`DNA
`cDNA
`mtDNA
`DNAase
`DNFB
`DNP
`
`Dopa
`dp, DP
`
`(Deutsches Reichs-Patent)-German
`patent
`double stranded
`dithiothreitol
`dynes
`entgegen, stereodescriptor, see
`Glossary
`the absorbanceof a solution
`containing one gram per 100 ml
`contained in a cell having an
`absorption path of one cm
`molar extinction coefficient (concn in
`g-moles/l)
`excitatory amino acid
`erythrocyte coated by antibody and
`complement
`experimental allergic
`encephalomyelitis
`electron capture
`eosinophil chemotactic factor of
`anaphylaxis
`electrocardiogram
`Enzyme Commission Number
`edition
`effective dose
`editor(s)
`ethylenediaminetetraacetic acid
`electroencephalogram
`(exempli gratia) for example
`epidermal growth factor
`the same (authors), plural of idem
`European Inventory of Existing
`Chemical Substances
`i
`electrocardiogram
`enzyme-linked immunosorbentassay
`electromotive force
`ethylenediamine (in formulas)
`stereochemical descriptor, see
`Glossary
`Environmental Protection Agency
`erythropoietin; European Patent
`Office
`molar extinction coefficient (concn in
`g-moles/1); dielectric constant
`equation
`equilibrium
`equivalent
`especially
`electrostatic units of electrical charge
`ethyl C,H;—
`viscosity
`(et alii) and others
`et cetera
`ether
`ethyl alcohol
`European patent application
`electron volt
`evacuated
`evaporation
`stereochemical descriptor, see
`Glossary
`experimental(ly)
`extract, extracted
`externally
`Fahrenheit degrees; also Fourneau
`fructose 1-phosphate
`fructose 6-phosphate
`fatty acid
`fast atom bombardment
`flavin adenine dinucleotide (reduced
`form)
`Freund’s complete adjuvant (same as
`CFA)
`ferredoxin
`Food and Drug Administration
`(U.S.A.)
`Food, Drug and Cosmetic (U.S.A).
`
`=pSO
`
`DeeBRPenfefrhedeSderMedehbehPoh
`
`ieeectsSSSSeecee
`
`FIAT
`
`FMN (FMNH))
`
`Fmoc
`Fortschr. Chem.
`Org. Naturst.
`
`fp
`FP
`FPLC
`Fr.pat.
`Frdi.
`
`GI
`g/l
`Gla
`Gle
`GLC
`GIcA
`GleN
`GlcNAc
`GICUA
`Gln
`Glu
`GluA
`Gly
`Glycerol-3-P
`Gmelin’s
`
`GMP
`
`cGMP
`GM-CSF
`
`gov't
`G
`
`(epsilon)
`
`eq
`equilib
`equiv
`esp
`esu
`Et
`1 (eta)
`et al.
`etc.
`Et,O
`EtOH
`Eur. pat. Appl.
`ev
`evac
`evapn
`exo-
`
`expt(ly)
`ext(d)
`extern
`°F
`F-1-P
`F-6-P
`FA
`FAB
`FAD (FADH)
`FCA
`
`Fd
`F.D.A.
`
`FD&C
`
`AQUESTIVE EXHIBIT 1076 Page 0005
`AQUESTIVE EXHIBIT 1076
`Page 0005
`
`
`xiv
`
`€
`

`

`graft-versus-host
`habitat
`homoarginine
`hemoglobin
`carbon monoxide hemoglobin;
`carboxyhemoglobin
`oxyhemoglobin
`humanchorionic gonadotropin
`homocysteine
`high density lipoproteins
`cells ofthe first continuously
`cultured (human cervical)
`carcinomastrain
`human gammaglobulin
`human growth hormone
`histidine
`human immunodeficiencyvirus
`ot-hydroxyisovaline
`human leukocyte antigen
`3-hydroxy-3-methylglutary]
`coenzyme A
`a German collection of medicinal
`patents
`Houben-Weyl Methoden der
`Organischen Chemie, a German
`collection of preparative methods
`in organic chemistry
`high performance(pressure, power)
`liquid chromatography
`hour
`human serum albumin
`homoserine
`.
`herpes simplex virus
`hydroxytryptamine (serotonin)
`cee T lymphotropicvirus see also
`hydroxylysine
`hydroxyproline
`optically inactive by internal
`compensation asi-inositol; archaic
`for meso-
`inosine
`Lregion antigen
`International Association of Cancer
`Registries
`International Agency for Research on
`Cancer
`IARC Monographs on the Evaluation
`of Carcinogenic Risk of Chemicals
`to Man
`(ibidem) at the same place
`Interstate Commerce Commission
`incomplete Freund’s adjuvant (same
`as FIA)
`interstitial cell-stimulating hormone
`(same as LH)
`insulin dependent diabetes mellitis
`the same (author); plural: eidem, the
`same(authors)
`inosine diphosphate
`(id est) thatis
`Isoelectric focusing
`interferon
`intragastric
`immunoglobulin
`Interessengemeinschaft der
`Farbenindustrie, Aktiengesellschaft-
`the German dye trust
`insulin-like growth factor |
`interleukin
`isoleucine
`intramuscular
`inosine 5'-monophosphate (inosinic
`acid)
`including
`incompatibility
`International Nonproprietary Name
`
`
`
`GVH
`habit.
`Har
`Hb
`HbCO
`
`HbO,
`HCG
`Hey
`HDL
`HeLa
`
`HGG
`HGH
`His
`HIV
`Hiv
`HLA
`HMG-CoA
`
`Houben
`
`Houben Weyl
`
`HPLC
`
`hr
`HSA
`Hse
`HSV
`HT
`HTLV
`
`Hyl
`HypL-
`
`IT
`
`a
`IACR
`
`IARC
`
`IARC Monographs
`
`ibid.
`LEG:
`ICFA
`
`ICSH
`
`IDDM
`idem
`
`IDP
`Le.
`JEF
`IF, IFN
`ig.
`Ig
`1G. Farben
`
`IGF-1
`IL
`Tle
`im.
`IMP
`
`incl
`incompat
`INN
`
`1-fluoro-2,4-dinitrobenzene
`fructose 1,6-diphosphate
`following
`free fatty acid
`free from chlorine
`Freund’s incomplete adjuvant (same
`as ICFA)
`Field Information Agency, Technical
`(U.S. reports)
`flavin mononucleotide (reduced
`form); same as riboflavin
`phosphate
`9-fluorenyimethoxycarbonyl
`Fortschritte der Chemie Organischer
`Naturstoffe (Progress in the
`Chemistry of Organic Natural
`Products)
`freezing point
`flavoprotein
`fast protein liquid chromatography
`French patent
`P. Friedlander Fortschritte der Teer-
`farbenfabrikation, a collection of
`patents
`fructose
`follicle-stimulating hormone
`Fourier transform
`gram(s)
`guanine; guanosine
`glucose 1-phosphate
`glyceraldehyde 3-phosphate
`glucose 6-phosphate
`‘y-aminobutyric acid
`gallon(s)
`galactose
`N-acetyl-p-galactosamine
`microgram(s)
`gas chromatography
`glutamate dehydrogenase
`guanosine diphosphate
`geminal, stereodescriptor see
`Glossary
`geological
`Germanpatent
`growth hormone
`gastrointestinal
`grams perliter
`y-carboxyglutamic acid
`glucose
`gas-liquid chromatography
`gluconic acid
`glucosamine
`N-acetyl-D-glucosamine
`glucuronic acid
`glutamine
`glutamic acid
`glucuronic acid
`glycine
`glycerol 3-phosphate
`Gmelin’s Handbuch der
`Anorganischen Chemie, a
`comprehensive German
`encyclopedia of inorganic
`chemistry
`guanosine 5'-monophosphate
`(guanylic acid)
`cyclic GMP
`granulocyte macrophage colony
`stimulating factor
`government
`glycoprotein
`growth hormonereleasingfactor
`glutathione (reduced)
`glutathione (oxidized)
`guanosinetriphosphate
`genitourinary
`guanine
`
`FMN (FMNH,)
`
`Fmoc
`Fortschr. Chem.
`Org. Naturst.
`
`GLC
`GIcA
`GIcN
`GlcNAc
`GIcUA
`Gin
`Glu
`GluA
`Gly
`Glycero]-3-P
`Gmelin’s
`
`GMP
`
`cGMP
`GM-CSF
`
`gov't
`
`GRF, GHRF
`GSH
`GSSG
`GTP
`GU
`Gua
`
`2ichs-Patent)-German
`ed
`
`‘eodescriptor, see
`e of a solution
`one gram per 100 ml
`nacell having an
`:
`path of one cm
`ion coefficient (concn in
`ino acid
`yated by antibody and
`it
`allergic
`ayelitis
`re
`emotactic factor of
`
`s z
`
`and Cosmetic (U.S.A).
`
`ram
`umission Number
`
`2 i
`
`netetraacetic acid
`ralogram
`ia) for example
`wth factor
`hors), plural ofidem
`‘entory of Existing
`substances
`gram
`:d immunosorbent assay
`> force
`ine (in formulas)
`al descriptor, see
`
`al Protection Agency
`a; European Patent
`
`ion coefficient (concn in
`, dielectric constant
`
`units of electrical charge
`
`others
`
`tent application
`
`-al descriptor, see
`
`(ly)
`icted
`
`egrees; also Fourneau
`1osphate
`losphate
`mbardment
`1e dinucleotide (reduced
`
`nplete adjuvant (same as
`
`ug Administration
`
`XV
`
`
`
`AQUESTIVE EXHIBIT 1076 Page 0006
`AQUESTIVE EXHIBIT 1076 Page 0006
`
`

`

`
`
`N.N.R.
`
`no.
`nor-
`
`NRDC
`
`NSAID(s)
`
`NSC
`NTP
`
`o-
`
`PAGE
`passim
`pat.
`PB report
`
`PCA
`PCT
`PEP
`PET
`Pr petrol
`FC
`3PG
`PG
`PGA
`PGP
`pH
`
`PHA
`Phe
`physiol
`pK
`
`PKU
`PMN
`PPj
`Ppm
`me
`BQ
`Pr
`Prepd
`Prepn
`press,
`‘°
`PRPP
`v(psi)
`H
`
`Q4
`
`-G.v.
`Q.v.
`-
`
`rr
`
`microgram
`millicurie
`
`100
`
`molecular rotation
`malate dehydrogenase
`methyl CH,—
`acetone
`methyl alcohol
`Mellor’s Comprehensive Treatise on
`Inorganic and Theoretical
`Chemistry
`milli-equivalent (0.001 of an
`equivalent)
`methionine
`N-formylmethionine
`methemoglobin
`millielectron volts
`manufacturing
`manufacture
`milligram
`major histocompatibility complex
`microcurie
`microgram
`microcrystalline
`migration inhibition factor
`minimum; minute(s)
`Mullerian inhibiting substance
`miscible
`mixture
`milliliter (cubic centimeter)
`minimum lethal dose
`mixed lymphocyte reaction
`millimeter
`millimicron(s), nm
`molecular weight
`Monatshefte fiir Chemie
`milliosmolar
`melting point; melts, melting at,
`when followed bya figure
`denoting temperature
`relative molecular mass
`magnetic resonance imaging
`meso- (internally compensated)
`mass spectrometry
`melanocyte-stimulating hormone
`(melanotropin)
`index ofrefraction (n29 for 20° and
`sodium light); normal, as n-propyl
`normal (equivalents perliter, as
`applied to concentration); nitrogen
`(as in N-methylpyridine)
`N-acetylneuraminic acid
`nicotinamide adenine dinucleotide
`(reduced form)
`nicotinamide adeninedinucleotide
`phosphate (reduced form)
`nonaspirin nonsteroidal anti-
`inflammatory drugs
`National Bureau of Standards
`National Collection of Type Cultures
`nucleoside 5’-phosphate
`Netherlands patentapplication
`National Formulary
`nanogram (107? grams)
`nerve growth factor
`Non-insulin dependent diabetes
`mellitis
`National Institute for Occupational
`Safety and Health
`nanometer
`nicotinamide mononucleotide
`(reduced form)
`nucleoside 5’-monophosphate
`nuclear magnetic resonance
`New and Nonofficial Drugs
`(Lippincott, 1959-1964)
`
`NMR NN.D.
`
`NAcneu
`NAD* (NADH)
`
`NADP* (NADPH)
`NANSAIDS
`
`NBS
`NCTC
`NDP
`Neth. pat. Appl.
`N.F.
`ng
`NGF
`NIDDM
`
`NIOSH
`
`nm
`NMN* (NMNH)
`NMP
`
`mcg
`mCi
`
`MD
`
`MDH
`Me
`Me.CO—
`MeOH
`Mellor’s
`
`mEq
`Met
`fMet
`MetHb
`meV
`mfg, manuf
`mfr
`mg
`MHC
`mCi
`mg
`microcryst
`MIF
`min
`MIS
`misc
`mixt
`mi
`MLD
`MLR
`mm
`my
`mol wt
`Monatsh.
`mOsm
`mp
`
`inorganic
`insoluble
`internal
`International
`intraperitoneal
`infrared
`immuneresponse genes
`Internal Organization for
`Standardization
`isolation
`inosine triphosphate; idiopathic
`thrombocytopenic purpura
`international unit
`International Union of Chemistry
`International Union of Pure and
`Applied Chemistry
`intravenous
`Japanese patent (unexamined)
`Japanese patent
`dissociation constant; equilibrium
`constant
`degrees Kelvin
`kilobase
`kilocalories(s)
`killer cell
`kilogram(s)
`a-ketoglutarate
`keyhole limpet hemocyanin
`kidney plasminogen activator
`liter
`levo(rotatory), the opposite of d
`levo (in configurational sense only),
`the opposite of D
`lactose
`lymphocyte-activating determinant
`wavelength
`laser microprobe mass analysis
`long acting thyroid stimulator
`pound(s)
`lethal concentration;liquid
`chromatography
`median lethal concentration, the
`concn of a chemical thatis
`estimated to be fatal to 50% ofthe
`organisms tested
`lymphocyte choriomeningitis
`lethal dose
`median lethal dose, the quantity of a
`chemical that is estimated to be
`fatal to 50% of the organisms
`tested
`lactate dehydrogenase
`low density lipoproteins
`leucine
`luteinizing hormone (same as ICSH)
`natural logarithm
`(loco citato) in the place cited
`logarithm (common)
`limit of impurities
`lipopolysaccharide
`lysine
`meter; given after mass number
`signifies metastable isomer
`meta chemical locantfor ring
`substituents
`molar (concentration)
`monoclonal antibody
`maximum allowable concentration
`macrophageactivating factor
`monoamine oxidase
`monoamine oxidase inhibitor
`mass spectrometry
`maximum, maxima
`myoglobin
`oxymyoglobin
`Manufacturing Chemists Association
`(U.S.A.)
`
`inorg
`insol
`intern
`ntl
`Lp.
`IR
`Ir genes
`ISO
`
`isoln
`ITP
`
`LU.|
`LUC.
`LU.P.A.C,
`
`Lv.
`Japan. Kokai
`Japan.pat.
`
`K *
`
`K
`Kb
`kcal
`K cell
`kg
`akG
`KLH
`KPA
`
`1LL
`
`-
`
`Lac
`LAD
`» (lambda)
`LAMMA
`LATS
`Ib
`LC
`
`LCsq
`
`LCM
`LD
`LDso
`
`LDH
`LDL
`Leu
`LH
`In
`loc. cit.
`log
`l.o.i.
`LPS
`Lysm
`
`m-
`
`M M
`
`ab, mAb
`MAC
`MAF
`MAO
`MAOI
`mass spec
`max
`Mb
`MbO,
`MCA.
`
`AQUESTIVE EXHIBIT 1076 Page 0007
`AQUESTIVE EXHIBIT 1076
`Page 0007
`
`
`
`
`xvi
`
`

`

`tabl
`
`R (
`
`RCO-
`recryst(n)
`re
`rep [REP]
`
`resp
`Ry Or Reg
`
`(S)-
`
`S.A.E.
`SAM
`sapon(if)
`Sar
`satd
`S.C.
`SDS
`sec
`sec-
`sepn
`Ser
`SI
`SLE
`SNRI
`
`sol; soly
`solidif
`soln
`sp.
`spec
`SPECT
`
`sp gt
`Spp.
`sq
`sqq
`SRBC
`SRS-A
`
`$s
`SSPE
`SSRI
`S.TP.
`subl
`suppl
`sym-
`syn-
`
`T t
`
`in
`
`
`
`N.N.R.
`
`NRDC
`
`NSAID(s)
`
`NSC
`NTP
`
`PABA
`PAF
`PAGE
`passim
`pat.
`PB report
`
`PCA
`PCT
`PEP
`PET
`petr, petrol
`PEC
`3PG
`PG
`PGA
`PGP
`
`se
`
`isive Treatise on
`eoretical
`
`101 of an
`
`bility complex
`
`1 factor
`
`3 g
`
`substance
`
`itimeter)
`se
`reaction
`
`r1emie
`
`ts, melting at,
`oy a figure
`‘ature
`mass
`e imaging
`sompensated)
`
`ating hormone
`
`1 (n38 for 20° and
`iormal, as n-propyl
`ts perliter, as
`entration); nitrogen
`pyridine)
`ic acid
`line dinucleotide
`
`iine dinucleotide
`iced form)
`roidal anti-
`rugs
`of Standards
`on of Type Cultures
`»sphate
`it application
`ary
`grams)
`tor
`ndent diabetes
`
`: for Occupational
`alth
`
`nonucleotide
`
`) m
`
`ophosphate
`: resonance
`‘cial Drugs
`359-1964)
`
`alkyl, univalent hydrocarbon radical
`New and Nonofficial Remedies
`(or hydrogen)
`(Lippincott, 1933-1958)
`rectus (right), stereodescriptorsee
`R)-
`number
`no.
`Glossary
`nor-
`chemical nomenclature descriptor,
`“JpX_molwt
`radioallergosorbent test
`RAST
`see Glossary
`100
`red blood cell; red blood count
`National Research Development
`aliphatic acyl radical
`recrystallize, recrystallization
`Corporation
`reference
`nonsteroidal anti-inflammatory
`“roentgen equivalent physical”’
`drugs
`means a doseof ionizing radiation
`National Service Center
`nucleoside 5’-triphosphate; National
`capable of producing energy
`Toxicology Program (U.S.)
`absorption of 93 ergs per gram of
`tissue
`ortho chemical locant for ring
`substituents
`respectively
`denoting attachment to oxygen,as in
`(in paper chromatography)ratio of
`O- acetylhydroxylamine
`movement of the bandto the front
`ovalbumin
`of the solvent
`oxaloacetate
`radioimmunoassay
`p-ribose
`optical density
`(opere citato) in the work cited
`radioimmunosorbenttest
`organic
`ribonucleic acid
`Occupational Safety and Health Act
`heterogeneous nuclear RNA
`osmolar
`messenger
`ounce(s)
`nuclear RNA
`concentration by weight (after optical
`ribosomal RNA
`rotations only)
`small nuclear RNA
`transfer (soluble) RNA
`page(s).
`para chemical locant for ring
`ribonuclease
`Registry of Toxic Effects of Chemical
`substituents
`Substances
`inorganic phosphate
`pascal
`symmetrical
`denoting attachmentto sulfur as in
`p-aminobenzoic acid
`platelet-activating factor
`S-methylcysteine
`polyacrylamide gel electrophoresis
`sinister (left), stereodescriptor see
`here and there, scattered
`Glossary
`Society of Automotive Engineers
`patent
`Publication Board Report (United
`S-adenosylmethionine
`States Department of Commerce,
`saponification
`Scientific and Industrial Reports)
`sarcosine
`passive cutaneous anaphylaxis
`saturated
`Patent Co-operation Treaty
`subcutaneous
`phosphoenolpyruvate
`sodium dodecy! sulfate
`positron emission tomography
`second(s)
`secondary
`petroleum
`laque-formingcell
`separation
`serine
`-phosphoglycerate
`International System of Units
`prostaglandin
`pteroylglutamic acid (folic acid)
`systemic lupus erythematosus
`3-phosphoglyceroyl phosphate
`serotonin-noradrenaline reuptake
`acid-base scale; log of reciprocal of
`inhibitor
`hydrogen ion concentration
`soluble; solubility
`phytohemagglutin
`solidifies, solidification
`solution
`phenylalanine
`hysiological
`species; specific
`og ofthe reciprocal of the
`spectroscopy
`dissociation constant, I/log K
`single photon emission computed
`phenylketonuria
`tomography
`polymorphonuclear leukocyte
`specific gravity
`inorganic pyrophosphate
`species (plural)
`parts per million
`square
`precipitate, precipitating
`(sequentia) and following
`precipitated
`sheep red blood cells
`slow reacting substance of
`plastoquinone
`propyl (normal)
`anaphylaxis
`prepared
`single stranded
`subacute sclerosing panencephalitis
`preparation
`selective serotonin reuptake inhibitor
`pressure
`standard temperature and pressure
`proline
`5-phosphoribosyl 1-pyrophosphate
`sublimes
`pseudo
`supplement
`point
`symmetrical
`parathyroid hormone
`stereochemical descriptor see
`coenzyme Q (ubiquinone)
`Glossary
`(quae vide) which see, plural
`thymine; thymidine
`(quod vide) which see
`half-life
`*roentgen’’ unit of radiation
`tablet(s)
`racemic
`
`xvii
`
`
`
`AQUESTIVE EXHIBIT 1076 Page 0008
`AQUESTIVE EXHIBIT 1076 Page 0008
`
`

`

`
`
`
`
`tuberculosis
`trichloroacetic acid; tricarboxylic
`acid
`thymus derived cell
`thoracic duct lymphocyte
`thymidine diphosphate
`O-(triethylaminoethy])-cellulose
`technical
`temperature
`tertiary
`thyrotropic hormone
`tetrahydrofuran
`tetrahydrofolic acid
`threonine
`thymine
`thin-layer chromatography
`thymidine 5’-monophosphate
`tobacco mosaic virus
`tumornecrosis factor
`trinitrophenyl
`tissue plasminogen activator
`thiamine pyrophosphate
`stereodescriptor see Glossary
`tris(hydroxymethyl)aminomethane;
`2-amino-2-hydroxymethylpropane-
`1,3-diol
`tryptophan
`thyroid-stimulating hormone
`tumor-specific transplantation
`antigens
`thymidine triphosphate
`tyrosine
`uracil or uridine
`uridine diphosphate
`uridine diphosphogalactose
`uridine disphosphoglucose
`United Kingdom
`uridine 5’-monophosphate (uridylic
`acid)
`uncorrected
`unsymmetrical, asymmetrical
`uracil
`United States Atomic Energy
`Commission
`United States Adopted Names
`
`TB, tb
`TCA
`
`T cell
`TDL
`TDP
`TEAEcellulose
`tech
`temp
`tert-
`TH
`THF
`THFA
`Thr
`Thy
`TLC
`TMP
`TMV
`TNF
`TNP
`TPA
`TPP, ThPP
`trans-
`Tris
`
`Trp
`TSH
`TSTA
`
`TTP, dTTP
`Tyr
`DP
`UDP-gal
`UDP-gic
`U.K.
`UMP
`
`UU
`
`uncor(r)
`uns-, unsym-
`Ura
`U.S.A.E.C.
`
`USAN
`
`U.S.D.
`U.S.D.A.
`
`U.S.P.
`US.pat.
`UTP
`uv
`Vv
`y-
`Val
`var
`viz.
`VLDL
`vol
`vs
`viv
`
`wbc
`WHO
`wks
`wt
`wiv
`
`w/w
`
`XMP
`yr(s)
`Z
`(Z)-
`
`Z. Physiol.
`
`sc
`=
`>
`<
`
`United States Dispensatory
`United States Department of
`Agriculture
`United States Pharmacopeia
`United States patent
`uridine triphosphate
`ultraviolet
`volt(s)
`vicinal (adjacent)
`valine
`variety
`(videlicet) that is to say; namely
`very low density lipoproteins
`volume
`versus
`percent ‘‘volume in volume’’
`expresses the numberof milliliters
`of an active constituent in 100
`milliliters of solution
`white blood cell; white blood count
`World Health Organization
`weeks
`weight
`percent ‘‘weight in volume’”’
`expresses the number of grams of
`an active constituent in 100
`milliliters of solution, and is used
`regardless of whether water or
`anotherliquid is the solvent
`percent ‘‘weight in weight’’
`expresses the number of grams of
`an active constituent in 100 grams
`of solution or mixture
`xanthosine monophosphate
`year(s)
`carbobenzoxy
`zusammen stereodescriptor see
`Glossary
`Hoppe-Seyler’s Zeitschriftfiir
`Physiologische Chemie
`approximately
`approximately equal
`greater than
`less than
`
`xviii
`
`AQUESTIVE EXHIBIT 1076 Page 0009
`AQUESTIVE EXHIBIT 1076 Page 0009
`a»
`
`

`

`
`
`3042
`
`Diazepam
`
`similar hydrocarbons. Morestable in alkaline formulatig
`then whenat neutral or acid pH. LDsgp in male, femaje Bi
`(mg/kg): 250, 285 orally (Gaines).
`as
`Caution: Cholinesterase inhibitor: Clinical Toxicology
`Commercial Products, R. E. Gosselin et al, Eds. (Witliant
`& Wilkins, Baltimore, 5th ed., 1984) Section II, p 294.
`USE:
`Insecticide.
`THERAP CAT (VET): Ectoparasiticide.
`
`Whetsel et al, J. Am.
`pote!
`pose & al, Acta Cryst. 17, 765
`N
`Me
`
`i
`

`S03
`
`
`
`
`
`7-Chloro-1,3-dihydro-1-methyl-5S-
`3042, Diazepam.
`phenyl-2H-1,4-benzodiazepin-2-one; 7-chloro-1-methyl-5-
`phenyl-3H-1,4-benzodiazepin-2(1H)-one; methyl diazepin-
`one; diacepin; LA-III; Ro-5-2807; Wy-3467; NSC-77518;
`Apaurin; Atensine; Atilen; Bialzepam; Calmpose; Ceregu-
`lart; Dialar; Diazemuls; Dipam; Eridan; Eurosan; Evacalm;
`Faustan; Gewacalm; Horizon; Lamra; Lembrol; Levium;
`Mandrozep; Neurolytril; Noan; Novazam; Paceum; Paci-
`tran; Paxate; Paxel (obsolete); Pro-Pam; Q-Pam; Relanium;
`Sedapam; Seduxen; Servizepam; Setonil; Solis; Stesolid;
`Tranquase; Tranquo-Puren; Tranquo-Tablinen; Unisedil;
`Valaxona; Valiquid; Valium; Valrelease; Vival; Vivol. Cy.-
`H,jCIN,O; mol wt 284.74. C 67.49%, H 4.60%, Cl 12.45%,
`N 9.84%, O 5.62%.
`Prepn:
`Sternbach, Reeder, J. Org.
`Chem. 26, 4936 (1961); Reeder, Sternbach, U.S. pat. 3,371,-
`085 (1968 to Hoffmann-La Roche); prepd but not claimed:
`eidem, U.S. pats. 3,109,843 and 3,136,815 (1963, 1964 to
`Hoffmann-La Roche); M. Gates, J. Org. Chem. 45, 1675
`(1980); M. Ishikura et al, ibid. 47, 2456 (1982). Purifica-
`tion: Chase, U.S. pat. 3,102,116 (1963 to Hoffmann-La
`Roche). Pharmacology: Hudson, Wolpert, Arch. Int. Phar-
`macodyn. Ther. 186, 388 (1970). Metabolism: Randall et
`al, Curr. Ther. Res. Clin. Exp. 7, 590 (1965); Van der
`Kleijn, Ann. N.Y. Acad. Sci. 179, 115 (1971). Toxicity: E. I.
`Goldenthal, Toxicol. Appl. Pharmacol. 18, 185 (1971). Bind-
`ing study in rat brain: R. F. Squires, C. Braestrup, Nature
`266, 732 (1977). Comprehensive description: A. Mac-
`Donald et al, Anal. Profiles Drug Subs. 1, 79-99 (1972).
`Clinical pharmacokinetics: M. Mandelli et al, Clin. Phar-
`macokinet. 3, 72 (1978).
`
`Plates from acetone + petr ether, mp 125-126". pK, 3.4.
`Sol in chloroform, DMF, benzene, acetone, alc; slightly sol
`in water. LDgo orally in rats: 710 mg/kg (Goldenthal).
`Note: This is a controlled substance (depressant) listed in
`ie a Codeof Federal Regulations, Title 21 Part 1308.14
`1995).
`THERAP CAT: Anxiolytic; muscle relaxant (skeletal).
`3043. Diazinon. Phosphorothioic acid O,O-diethyl O-
`[6-methyl-2-(1-methylethyl)-4-pyrimidinyl] ester; thiophos-
`phoric acid 2-isopropyl-4-methyl-6-pyrimidyl diethyl ester;
`O,O-diethyl O-2-isopropyl-4-methyl-6-pyrimidyl thiophos-
`phate; diethyl 2-isopropyl-4-methyl-6-pyrimidyl thiono-
`phosphate; dimpylate; G-24480; Antigal; Basudin; Diazol;
`D-z-n; Garden Tox; HelfaCat; HelfaDog; Neocidol; Parasi-
`tex; Sarolex; Spectracide; Taberdog; Tabergat. C,,H,,N,0;-
`PS; mol wt 304.35. C 47.36%, H 6.95%, N 9.20%, O
`15.77%, P 10.18%, S 10.54%. Prepn: Gysin, Margot, U.S.
`pat. 2,754,243 (1956 to Geigy).
`Insecticidal properties:
`Gasser, Z. Naturforsch. 8b, 225 (1953). Toxicity data: T. B.
`Gaines, Toxicol. Appl. Pharmacol. 14, 515 (1969).
`
`HC
`Q
`Hee.__-O\,-
`Ils
`
`o
`
`CH
`
`CH,
`
`N
`N
`| ZN
`
`CHg
`
`
`
`
`H
`
`mee
`0
`ye
`
`A
`M
`Oo
`ds
`N Oo”cH,
`
`H
`
`o
`
`Orangeneedles from ethanol, mp 230° (dec); also reported
`as yellowish-brown crystals from ethanol decomposing #
`temperatures above 250° (Petersen).
`uv max (methanol):
`340 nm (log € 4.17). Soly in water: 0.5 mg/ml. LD»™
`mice (mg/m?): 30.9 i.v. (Bender).
`THERAP CAT: Antineoplastic.
`3045. Diazoacetic Ester. Ethyl diazoacetate city
`diazoethanoate. C,H,N,O,; mol wt 114.10. C 42.11
`5.30%, N 24.55%, O 28.04%.
`-N=N*=CHCOOG!s
`Prepd by the action of sodium nitrite on glycine ethyl at
`hydrochloride: Curtius J. Prakt. Chem.
`[2] 38, 396Oo
`Silberrad, J. Chem. Soc. 81, 600 (1902); Womack,
`i
`Org. Syn. 24, 56 (1944).
`Yellow oil. Pungent odor. Very volatile. Exp’losive- a
`tillation, even under reduced pressure, is dangerous. ]P ~ 44
`dl76 1.0852. bp, 42°: bpy 45° bpgy 85-86% Pr | ia
`nj1.4588. Slightly sol in water. Neutral reaction|
`:
`tile with steam, ether, and benzene vapors. Miscible wit
`alcohol, benzene,
`ligroin, ether. Explodes on contae
`r
`4
`concd H,SO,.
`Ee
`+
`cent
`3046. Diazoaminobenzene.
`1,3-Diphenyl-14t wi
`anilinoazobenzene; benzeneazoaniline.
`CpyoHuNe giazol
`197.24. C 73.07%, H 5.62%, N 21.30%. Made by dind
`ing aniline dissolved in HCl with NaNO,and then 2° on
`coned soln of sodium acetate: Hartman, Dickey:
`coll. vol, II, 163 (1943).
`
`[2,5-Bis(1-aziridinyl)-3,6-dioxo.4 4.
`3044, Diaziquone.
`cyclohexadiene-1,4-diyl]biscarbamic acid diethyl ester, 25.
`|
`bis(1-aziridinyl)-3,6-dioxo-1,4-cyclohexadiene-1,4-dicarbam;,
`j
`acid diethyl ester; 2,5-diaziridiny!-3,6-bis(ethoxycarbony,,
`amino)-1,4-benzoquinone; aziridinylbenzoquinone; AZO;
`CI-904; NSC-182986. CH»N,Og mol wt 364.36, 6
`52.74%, H 5.53%, N 15.38%, O 26.35%. Quinone-contaip.
`White or slightly red crysta
`ing lipophilic alkylating agent. Prepn as intermediatei,
`py heat, a blow, or on rubbing
`dyestuffs:
`S. Petersen et al, U.S. pat. 2,913,453 (1959 to
`Slightly sol in cold water, alcot
`Schenley Ind.). Synthesis and antitumor activity: A.
`alkalies, HCl.
`Khan, J. S. Driscoll, J. Med. Chem. 19, 313 (1976); 1.5
`use: As reagentfor phenol,i
`Driscoll et al, U.S, pat. 4,146,622 (1979 to U.S. Gov't).
`In
`aldehydes, and albumin; also
`vivo antitumor studies:
`J. S. Driscoll et al, J. Pharm. Sci
`dyes.
`68, 185 (1979).
`Intracerebral penetration and tissue dis.
`i
`tribution in humans: N.Savaraj et al, J. Neuro-Oncol. 1, 15
`0 ”a Zateas,
`(1983). LC determn: B. A. Allen et al, J. Chromatog. 221,
`Prepd from chloroform and
`146 (1981). Pharmacokinetics: S. Zimm et al, Cancer Res
`potassium hydroxide: Staud
`|
`44, 1698 (1984). Clinical studies in treatment of CNSneo-
`1912); McM
`t
`plasms: R. T. Eagan et al, J. Neuro-Oncol. 5, 309 (1987); B.
`Tapazoglou et al, Am. J. Clin. Oncol. 11, 474 (1988). Re- esie
`view: J. F. Bender et al., Invest. New Drugs 1, 71-84 (1983).
`Chim. France 1963, 41. These
`a
`|
`methane. The following pro.
`diazomethane. From N-niti
`methyl ketone in ether and i:
`sodium isopropoxide or from
`Teaction with sodium cyclohex:
`Syn, 25, 28 (1945). By KO
`methylurea in ether: Arndt,
`(1943), or of nitrosomethyluret
`Ber. 27, 1888 (1894); 28, 855
`Ber. 61, 1845 (1928).
`In the 1
`be Prepd most simply by the
`mercially available N-methyl-
`McKay, J. Am. Chem. Soc
`e Can, J. Res. 28, 683 (195C
`; emistry (Reinhold, New Yo
`ete intermediate:
`p-toly
`5 lazald” Aldrich Chemical
`"8. Syn. coll. vol, IV, 250 (16
`lous
`poj
`:
`_'¥ toxic yellow gas. Explc
`Bold mae 2 well-ventilated
`
`solns may
`exnj> — 145°; bp
`
`Y explode violently, es
`100°
`osseous diazomethane
`
`or on r
`and glass sti ‘ough glass surfac
`ay O
`lrers with glass sl
`Plosionswren not be used
`8olns deg ote diazomethane.
`
`if alcohols
`Y slowly at lowte
`tive
`Or water are pres
`Mation ofmeen with the evolu
`calc:
`insol white flakes
`of
`(Sy
`:
`akes 0:
`
`Thispp chloride or boiling s
`
`Of diag
`vomenon appears to 0
`; eaeethane on solid subsi
`
`IN, Shortaertential symptom
`Chest
`peness Of breath; head
`%8thma.Pulmonary edema.
`Nazargs atigue.
`See NIOSE
`Pbira¢OAHS/NIOSH 90-1
`QorO
`
`ficken, Sek
`276”Mterscience’ Noeee
`wit
`Usp.
`des
`0,
`t
`: p
`
`Golden-yellow, small crystals. mp 98°; explo th
`8 carp, OWerful
`—
`heated to 150°.
`Insol in water; freely sol in bem! me
`RomaneHc acids,pres!
`
`Liquid. Faint ester-like odor. d3? 1.116-1.118. bppoq. 83-
`(193
`e se,
`e
`nd
`hot alc.
`gfe
`ed ~ Bist, = the reviews by
`84°.
`n#0 1.4978-1.4981. Vapor pressure at 20° 1.4 10-4
`Z. An
`3047. p-Diazobenzenesulfonic Acid. 4-sulfnOre
`.
`>Pa:
`-
`Angew. Chen
`at 40°: 1.1> 10-3 (~5 times vapor pressure of parathion).
`Regrtry at in Newer Me
`diazonium inner salt; sulfanilic acid diazide. Ce 600%
`Volatility at 20°: 2.4 mg/m3; at 40°: 17.6 mg/m3. Decom-
`ew York, 1948)
`poses above 120°. Soly in water at 20°: 0.004%. Méiscible
`mol wt 184.18. C 39.13%, H 2.19%, N 15.21%,
`nd 5
`*2Gohn Wiley,
`with alcohol, ether

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket